Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab

BACKGROUND: The vast majority of patients with HER2-positive metastatic breast cancer (MBC) treated with trastuzumab eventually develop resistance to this agent. There is an unmet need therefore, for identifying biological markers with possible prognostic/predictive value in such patients. The aim o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fountzilas, George, Christodoulou, Christos, Bobos, Mattheos, Kotoula, Vassiliki, Eleftheraki, Anastasia G, Xanthakis, Ioannis, Batistatou, Anna, Pentheroudakis, George, Xiros, Nikolaos, Papaspirou, Irene, Koumarianou, Anna, Papakostas, Pavlos, Bafaloukos, Dimitrios, Skarlos, Dimosthenis V, Kalogeras, Konstantine T
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3499161/
https://ncbi.nlm.nih.gov/pubmed/23092535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars